Doron Therapeutics

Chapel Hill, United States

Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drug derived from placental tissue.

$11.0M raised

Nov 2024

Series A

Biotechnology

Top Investors

SPRIM Global Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Doron Therapeutics

How much funding has Doron Therapeutics raised?

Doron Therapeutics has raised $11.0M in total funding. The most recent round was Series A. The last funding was announced in November 2024.

Who are Doron Therapeutics's investors?

Doron Therapeutics's investors include SPRIM Global Investments.

Where is Doron Therapeutics headquartered?

Doron Therapeutics is headquartered in Chapel Hill, United States.

What does Doron Therapeutics do?

Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drug derived from placental tissue.

What stage is Doron Therapeutics at?

Doron Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 25, 2024.

MLA

"Doron Therapeutics — Funding & Investors." VCBacked, November 25, 2024, https://www.vcbacked.co/company/doron-therapeutics. Accessed June 16, 2026.

APA

VCBacked. (2024). Doron Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/doron-therapeutics

Wikipedia (cite web)

{{cite web |title=Doron Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/doron-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 25, 2024.

Similar Companies in Biotechnology